In-Licensing Lessons: Benchmarking Best Practice | Evaluate
Leverage biotechs for pipeline boost with reduced risk. Navigate the large ecosystem to select assets fitting your strategy for successful partnerships.| Evaluate
Leverage biotechs for pipeline boost with reduced risk. Navigate the large ecosystem to select assets fitting your strategy for successful partnerships.| Evaluate
Andrew Ward discusses the role of analogs in pharmaceutical forecasting and shares best practices their successful use in this short video.| Evaluate
Discover how pharma and biotech are converging in a consumer-driven landscape. Learn about direct-to-patient models, carve-out deals, and why some biotechs are going solo. Get early access to insights from “Pharma v Biotech: New Rules?” and stay ahead of the curve.| Evaluate
Discover how biotech and Big Pharma are evolving under pressure. From China’s R&D surge to pricing reform, we reveal key market shifts that are reshaping the pharma landscape.| Evaluate
Discover how a configurable treatment value model empowers pharmaceutical companies, healthcare professionals, and patients in emerging therapeutic markets—enhancing drug launch strategies, treatment access, and clinical decision-making with real-world data and cost transparency.| Evaluate
Andrew Ward discusses the continued relevance of Excel-based forecasting as part of a forecasters software toolkit, highlighting its flexibility, transparency, and universal accessibility.| Evaluate
The obesity sector has witnessed robust GLP-1 deal making with pharma companies showing unprecedented appetite for strategic pharma deals.| Evaluate
Discover how pharma forecasting teams can navigate Loss of Exclusivity (LoE) with precision. Learn strategies to manage asset saturation, biosimilar impact, and regional planning in today’s competitive pipeline landscape.| Evaluate
“Nuclear winter” and “extinction event” were two of the less-than-positive terms used during last month’s BIO International convention to describe the biotech investment landscape..| Evaluate
Pharma industry trends 2025. Find 3 standout insights from Evaluate’s World Preview 2025 webinar, including the rise of integrated biotechs & China’s growing role. Watch now on demand.| Evaluate
